SPDR S&P Pharmaceuticals ETF
XPH
XPH
65 hedge funds and large institutions have $256M invested in SPDR S&P Pharmaceuticals ETF in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8.56% more ownership
Funds ownership: 63.85% → 72.41% (+8.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
65
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$56.3M | |
| 2 | +$9.1M | |
| 3 | +$4.38M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.7M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.19M |
Top Sellers
| 1 | -$5.5M | |
| 2 | -$4.79M | |
| 3 | -$3.74M | |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$3.12M |
| 5 |
LPL Financial
San Diego,
California
|
-$2.13M |